These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4640712)

  • 1. [Lymphocytic reactivity to PHA in the course of diverse hepatic diseases].
    Poujoulet N; Dambrin G; Colombies P; Ducos J
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):117-8. PubMed ID: 4640712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte transformational reactivity in chronic hepatitis and liver cirrhosis].
    Epishina NA; Sytnik IA; Epishin AV
    Vrach Delo; 1978 Jul; (7):65-70. PubMed ID: 685258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphocyte transformation in chronic hepatitis and other hepatic diseases].
    Scheiffarth F; Warnatz H; Ottenjann R; Ritter H
    Arch Klin Med; 1969; 216(5):447-56. PubMed ID: 4984373
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.
    Hsu CC; Leevy CM
    Clin Exp Immunol; 1971 May; 8(5):749-60. PubMed ID: 5581064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of lymphocyte subpopulations by stimulation with polyclonal mitogens in chronic liver diseases].
    Nicolaescu T; Bordea M; Bordeianu A; Bittman E; Stoiculescu P; Udrescu E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):167-74. PubMed ID: 6139862
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.
    Hsu CS; Leevy CM
    Med Chir Dig; 1973; 2(1):9-11. PubMed ID: 4729533
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibited lymphocytic response to phytohemagglutinin (PHA) in acute infectious hepatitis and in chronic aggressive hepatitis; indirect evidence for virus persistence in chronic aggressive hepatitis?
    Martini GA; Rössler R; Havemann K; Dölle W
    Scand J Gastroenterol Suppl; 1970; 7():39-42. PubMed ID: 5271845
    [No Abstract]   [Full Text] [Related]  

  • 8. Study on autoimmune phenomenon in liver diseases. Blastoid cell transformation of lymphocytes cultured with autologous liver homogenate.
    Shishido H; Enomoto H; Okuda M
    Bull Tokyo Med Dent Univ; 1970 Mar; 17(1):9-18. PubMed ID: 5266559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphocyte reactivity in chronic hepatitis and hepatic cirrhosis].
    Tacorian S; State I; Dumitrescu M; Runcan V
    Med Interna (Bucur); 1972 Jun; 24(6):721-6. PubMed ID: 5069810
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymphocyte transformation phenomenon in patients with chronic hepatitis and liver cirrhosis].
    Kaznacheev VP; Gichev IuP; Davidik GS
    Ter Arkh; 1972 May; 44(5):48-51. PubMed ID: 5069075
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis-associated, antigen-induced lymphocyte transformation in chronic hepatic disease.
    Pettigrew N; Russell RI
    Gut; 1972 Oct; 13(10):852-3. PubMed ID: 5087114
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the subpopulation and function of peripheral lymphocytes, and inhibitor to PHA stimulation existing in the serum of patients with liver disease.
    Nakao M; Mizoguchi Y; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1975; 10(4):307-15. PubMed ID: 1086263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diminished phytohemagglutinin stimulation of human lymphocyte cultures in liver cirrhosis: studies with 3H-thymidine and I-125 desoxyuridine].
    Surianu P; Heiniger HJ; Feinendegen LE
    Blut; 1970; 20(6):370-7. PubMed ID: 5423614
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibited lymphocytic response to phytohaemagglutinin (PHA) in chronic aggressive hepatitis.
    Jöbsis AC
    J Pathol; 1973 Jan; 109(1):Pxvii. PubMed ID: 4719768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic reactions after use of autologic hepatitis antigen in chronic liver diseases].
    Kaznacheev VP; Gichev IuP
    Klin Med (Mosk); 1973 Jan; 51(1):84-9. PubMed ID: 4764848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of new immunological tests in chronic hepatitis and liver cirrhosis].
    Kurdybaĭlo FV; Kovalenko GT; Krivulia AV
    Vrach Delo; 1974 May; 5(0):76-9. PubMed ID: 4601529
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cellular immunity in chronic hepatitis and cirrhosis of the liver in response to Australia antigen].
    Tareev EM; Kantorovich RA; Traianova TG; Lenchik VI; Mazharov MK
    Sov Med; 1973 May; 36(5):3-6. PubMed ID: 4768343
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological indicators in chronic hepatitis and liver cirrhosis].
    Podymova SD; Bon KU
    Sov Med; 1980; (12):38-41. PubMed ID: 6971495
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of various indices of T and B immunity systems in patients with chronic hepatitis and liver cirrhosis].
    Epishina NA; Sytnik IA; Epishin AV
    Vrach Delo; 1983 Aug; (8):94-8. PubMed ID: 6605624
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G; Chastenay BF; Krawitt EL
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.